Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases

Academic Article

Abstract

  • © 2015 The Author 2015. Background. Longitudinal studies have consistently found a significant association between bacterial vaginosis (BV) and acquisition of sexually transmitted diseases. However, there are limited prospective data to confirm these findings. Methods. We conducted a prospective, randomized, open-label trial of home screening and treatment of young women with asymptomatic BV who were also at high risk for sexually transmitted diseases. These women were screened every 2 months for 12 months and randomized to treatment with oral metronidazole 500 mg twice daily for 7 days or observation alone. The primary outcome was the incidence of gonorrhea and/or chlamydia. Results. A total of 1365 subjects were enrolled in the study across 10 sites. Adherence with mailing specimens obtained at home was excellent in both groups (84%-88%). The incidence of gonorrhea and/or chlamydia was 19.1 per 100 person-years (95% confidence interval, 15.1-22.1) for the treatment group and 18.5 per 100 person-years (15.1-22.8) for the observation arm, a difference that was not statistically significant. Conclusions. Young women were very amenable to home screening for BV, gonorrhea, and chlamydia. Treatment of asymptomatic BV with 1 week of oral metronidazole did not decrease the incidence of gonorrhea and/or chlamydia.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Schwebke JR; Lee JY; Lensing S; Philip SS; Wiesenfeld HC; Seña AC; Trainor N; Acevado N; Saylor L; Rompalo AM
  • Start Page

  • 531
  • End Page

  • 536
  • Volume

  • 62
  • Issue

  • 5